Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 6.54859676 |
2 | cardiac myofibril assembly (GO:0055003) | 6.53319256 |
3 | * tricarboxylic acid cycle (GO:0006099) | 5.77788723 |
4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.71698296 |
5 | lysine catabolic process (GO:0006554) | 5.70111881 |
6 | lysine metabolic process (GO:0006553) | 5.70111881 |
7 | myofibril assembly (GO:0030239) | 5.63335792 |
8 | skeletal muscle contraction (GO:0003009) | 5.58921967 |
9 | 2-oxoglutarate metabolic process (GO:0006103) | 5.49084588 |
10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.47385574 |
11 | regulation of cell communication by electrical coupling (GO:0010649) | 5.41090653 |
12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.28424031 |
13 | carnitine shuttle (GO:0006853) | 5.24496011 |
14 | actin filament-based movement (GO:0030048) | 5.20992884 |
15 | fatty acid transmembrane transport (GO:1902001) | 4.97335876 |
16 | aspartate family amino acid catabolic process (GO:0009068) | 4.87894801 |
17 | cardiac muscle contraction (GO:0060048) | 4.87448785 |
18 | actin-myosin filament sliding (GO:0033275) | 4.83648737 |
19 | muscle filament sliding (GO:0030049) | 4.83648737 |
20 | fatty acid beta-oxidation (GO:0006635) | 4.82582022 |
21 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.80682676 |
22 | cardiac muscle cell development (GO:0055013) | 4.70173450 |
23 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.62669577 |
24 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.62013720 |
25 | glyoxylate metabolic process (GO:0046487) | 4.59196912 |
26 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.54801973 |
27 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.47860456 |
28 | cardiac muscle hypertrophy (GO:0003300) | 4.47636356 |
29 | response to inactivity (GO:0014854) | 4.45031144 |
30 | cardiac cell development (GO:0055006) | 4.40829269 |
31 | regulation of sarcomere organization (GO:0060297) | 4.40480573 |
32 | response to muscle activity (GO:0014850) | 4.35755656 |
33 | regulation of relaxation of muscle (GO:1901077) | 4.34476878 |
34 | cellular ketone body metabolic process (GO:0046950) | 4.29262366 |
35 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.26153449 |
36 | heart trabecula formation (GO:0060347) | 4.25148341 |
37 | regulation of actin filament-based movement (GO:1903115) | 4.25137638 |
38 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.22743112 |
39 | striated muscle hypertrophy (GO:0014897) | 4.21693176 |
40 | fatty acid oxidation (GO:0019395) | 4.20064998 |
41 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.17440313 |
42 | tricarboxylic acid metabolic process (GO:0072350) | 4.16160035 |
43 | carnitine transmembrane transport (GO:1902603) | 4.14620056 |
44 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.14340152 |
45 | fatty acid catabolic process (GO:0009062) | 4.11579742 |
46 | heart contraction (GO:0060047) | 4.11466034 |
47 | heart process (GO:0003015) | 4.11466034 |
48 | muscle contraction (GO:0006936) | 4.11287842 |
49 | adult heart development (GO:0007512) | 4.11121455 |
50 | actomyosin structure organization (GO:0031032) | 4.11028458 |
51 | lipid oxidation (GO:0034440) | 4.10693226 |
52 | amino-acid betaine transport (GO:0015838) | 4.08318767 |
53 | carnitine transport (GO:0015879) | 4.08318767 |
54 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.07381773 |
55 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.07345355 |
56 | carnitine metabolic process (GO:0009437) | 4.06491204 |
57 | plasma membrane repair (GO:0001778) | 4.03639666 |
58 | actin-mediated cell contraction (GO:0070252) | 4.03477829 |
59 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.00773071 |
60 | skeletal muscle adaptation (GO:0043501) | 3.98395013 |
61 | amino-acid betaine metabolic process (GO:0006577) | 3.96275281 |
62 | kynurenine metabolic process (GO:0070189) | 3.95454408 |
63 | regulation of skeletal muscle contraction (GO:0014819) | 3.94886003 |
64 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93812610 |
65 | oxaloacetate metabolic process (GO:0006107) | 3.92221990 |
66 | branched-chain amino acid catabolic process (GO:0009083) | 3.92154928 |
67 | short-chain fatty acid metabolic process (GO:0046459) | 3.91107144 |
68 | acetyl-CoA metabolic process (GO:0006084) | 3.84960231 |
69 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.84283496 |
70 | regulation of fatty acid oxidation (GO:0046320) | 3.82905467 |
71 | muscle hypertrophy (GO:0014896) | 3.79492540 |
72 | valine metabolic process (GO:0006573) | 3.79081970 |
73 | NADH metabolic process (GO:0006734) | 3.78425827 |
74 | regulation of sequestering of triglyceride (GO:0010889) | 3.77248509 |
75 | response to epinephrine (GO:0071871) | 3.76505101 |
76 | monocarboxylic acid catabolic process (GO:0072329) | 3.73674449 |
77 | ketone body metabolic process (GO:1902224) | 3.73625874 |
78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.73209468 |
79 | L-phenylalanine metabolic process (GO:0006558) | 3.73209468 |
80 | muscle system process (GO:0003012) | 3.73081603 |
81 | muscle tissue morphogenesis (GO:0060415) | 3.72547983 |
82 | branched-chain amino acid metabolic process (GO:0009081) | 3.71524810 |
83 | regulation of cofactor metabolic process (GO:0051193) | 3.70907743 |
84 | regulation of coenzyme metabolic process (GO:0051196) | 3.70907743 |
85 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.70637962 |
86 | L-phenylalanine catabolic process (GO:0006559) | 3.70371882 |
87 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.70371882 |
88 | glycogen catabolic process (GO:0005980) | 3.68028774 |
89 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.64642476 |
90 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.64642476 |
91 | relaxation of cardiac muscle (GO:0055119) | 3.64627042 |
92 | striated muscle contraction (GO:0006941) | 3.62031867 |
93 | succinate metabolic process (GO:0006105) | 3.60060590 |
94 | alpha-linolenic acid metabolic process (GO:0036109) | 3.52301484 |
95 | regulation of striated muscle contraction (GO:0006942) | 3.46251243 |
96 | striated muscle adaptation (GO:0014888) | 3.46054911 |
97 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.43882460 |
98 | oxidative phosphorylation (GO:0006119) | 3.42488906 |
99 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.42101497 |
100 | quaternary ammonium group transport (GO:0015697) | 3.38962321 |
101 | glucan catabolic process (GO:0009251) | 3.37888319 |
102 | aromatic amino acid family catabolic process (GO:0009074) | 3.33888905 |
103 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.33521124 |
104 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.33308772 |
105 | muscle hypertrophy in response to stress (GO:0003299) | 3.33308772 |
106 | cardiac muscle adaptation (GO:0014887) | 3.33308772 |
107 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.32970850 |
108 | regulation of the force of heart contraction (GO:0002026) | 3.32848280 |
109 | positive regulation of fatty acid oxidation (GO:0046321) | 3.32304439 |
110 | creatine metabolic process (GO:0006600) | 3.31944419 |
111 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.26366232 |
112 | 4-hydroxyproline metabolic process (GO:0019471) | 3.26050063 |
113 | regulation of sulfur metabolic process (GO:0042762) | 3.24755569 |
114 | relaxation of muscle (GO:0090075) | 3.24611238 |
115 | muscle fiber development (GO:0048747) | 3.24445286 |
116 | cell communication involved in cardiac conduction (GO:0086065) | 3.22045781 |
117 | ethanol oxidation (GO:0006069) | 3.20521964 |
118 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.20512305 |
119 | cellular polysaccharide catabolic process (GO:0044247) | 3.20141002 |
120 | positive regulation of cation channel activity (GO:2001259) | 3.19995293 |
121 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.17037199 |
122 | myotube cell development (GO:0014904) | 3.16661079 |
123 | regulation of triglyceride catabolic process (GO:0010896) | 3.15105039 |
124 | cellular response to epinephrine stimulus (GO:0071872) | 3.14533635 |
125 | phospholipid homeostasis (GO:0055091) | 3.12603687 |
126 | biotin metabolic process (GO:0006768) | 3.11523935 |
127 | skeletal muscle fiber development (GO:0048741) | 3.11266397 |
128 | regulation of cardiac muscle contraction (GO:0055117) | 3.10854024 |
129 | muscle cell cellular homeostasis (GO:0046716) | 3.09005987 |
130 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.08276511 |
131 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.08276511 |
132 | regulation of ATPase activity (GO:0043462) | 3.04177746 |
133 | regulation of ATP catabolic process (GO:1903289) | 3.04177746 |
134 | regulation of membrane repolarization (GO:0060306) | 3.01505775 |
135 | skeletal muscle tissue development (GO:0007519) | 3.01146191 |
136 | glycogen biosynthetic process (GO:0005978) | 2.99667813 |
137 | glucan biosynthetic process (GO:0009250) | 2.99667813 |
138 | skeletal muscle tissue regeneration (GO:0043403) | 2.98078506 |
139 | polysaccharide catabolic process (GO:0000272) | 2.94243341 |
140 | striated muscle atrophy (GO:0014891) | 2.91633476 |
141 | striated muscle cell development (GO:0055002) | 2.90818185 |
142 | response to caffeine (GO:0031000) | 2.89259324 |
143 | regulation of muscle system process (GO:0090257) | 2.87929411 |
144 | regulation of muscle contraction (GO:0006937) | 2.83120884 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.60974257 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.77717483 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77559687 |
4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.30182467 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.77127263 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.26605094 |
7 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.03663467 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.73579022 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.57002927 |
10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.53192142 |
11 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.40740448 |
12 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.21999362 |
13 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.06890267 |
14 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.06831551 |
15 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.06831551 |
16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.73940993 |
17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.67891924 |
18 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.51585285 |
19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46723234 |
20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.34741312 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.33069486 |
22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.23177179 |
23 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.22427487 |
24 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.16272207 |
25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13091754 |
26 | GATA1_22025678_ChIP-Seq_K562_Human | 2.12513311 |
27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.10455793 |
28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.09168386 |
29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.07550074 |
30 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.97431988 |
31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.95818605 |
32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.89724993 |
33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.84256552 |
34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81934774 |
35 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.81108889 |
36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76746772 |
37 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72439338 |
38 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.72245432 |
39 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.69986011 |
40 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.68806846 |
41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68528878 |
42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67539015 |
43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66923637 |
44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66764230 |
45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65664339 |
46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64978744 |
47 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.61007193 |
48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60831757 |
49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59710848 |
50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59695467 |
51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.59157666 |
52 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.58800928 |
53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54185678 |
54 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.53168089 |
55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52694544 |
56 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.52374037 |
57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50942339 |
58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50091058 |
59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49607556 |
60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49135957 |
61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48282078 |
62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39507988 |
63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39193044 |
64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38930796 |
65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.38610212 |
66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.36924911 |
67 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.34600090 |
68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34522696 |
69 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32328603 |
70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32216185 |
71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31099476 |
72 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27909240 |
73 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26493103 |
74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24407470 |
75 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.23870879 |
76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23566299 |
77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22638625 |
78 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.22516566 |
79 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21927106 |
80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21508792 |
81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21261599 |
82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20408556 |
83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18812114 |
84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18136634 |
85 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17531814 |
86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17208084 |
87 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16226922 |
88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14957485 |
89 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14890733 |
90 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14803901 |
91 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14803901 |
92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14403112 |
93 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14256933 |
94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12047485 |
95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11327844 |
96 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10396813 |
97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10080985 |
98 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09807949 |
99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09278263 |
100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09175689 |
101 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08414072 |
102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07916985 |
103 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07496563 |
104 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06699739 |
105 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06528257 |
106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05744966 |
107 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04655542 |
108 | TBL1_22424771_ChIP-Seq_293T_Human | 1.04268835 |
109 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04009782 |
110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03999596 |
111 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03719416 |
112 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03536503 |
113 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02941254 |
114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02812769 |
115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02666304 |
116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02567297 |
117 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.02510297 |
118 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02107178 |
119 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01993325 |
120 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01421869 |
121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00129656 |
122 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96256312 |
123 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95943126 |
124 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94432380 |
125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92684145 |
126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92591055 |
127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91944729 |
128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90791596 |
129 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86910466 |
130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85942401 |
131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85439472 |
132 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84071841 |
133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83381958 |
134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82024141 |
135 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.81738525 |
136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.78399052 |
137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78333983 |
138 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76826982 |
139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75990606 |
140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72804158 |
141 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72482744 |
142 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70981607 |
143 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.70929544 |
144 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.69840036 |
145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69085135 |
146 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.68101159 |
147 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.67192655 |
148 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67010888 |
149 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66912884 |
150 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66912884 |
151 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66408547 |
152 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.66108703 |
153 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65957346 |
154 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.65829613 |
155 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.65021150 |
156 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64376887 |
157 | ATF3_27146783_Chip-Seq_COLON_Human | 0.64023892 |
158 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63114728 |
159 | CJUN_26792858_Chip-Seq_BT549_Human | 0.62854860 |
160 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61559641 |
161 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.61523698 |
162 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.60443635 |
163 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60279611 |
164 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.59999847 |
165 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.59172230 |
166 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.59061837 |
167 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.57994290 |
168 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.57762017 |
169 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57504249 |
170 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57410326 |
171 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.56793970 |
172 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56675560 |
173 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.56472711 |
174 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55895124 |
175 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.55567616 |
176 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.55223971 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 5.74742106 |
2 | MP0004084_abnormal_cardiac_muscle | 4.83733740 |
3 | MP0003646_muscle_fatigue | 4.44419885 |
4 | MP0004215_abnormal_myocardial_fiber | 3.93643337 |
5 | MP0000751_myopathy | 3.77027301 |
6 | MP0004036_abnormal_muscle_relaxation | 3.51492503 |
7 | MP0005330_cardiomyopathy | 3.45866797 |
8 | MP0005360_urolithiasis | 3.34846204 |
9 | MP0002139_abnormal_hepatobiliary_system | 3.32966542 |
10 | MP0005085_abnormal_gallbladder_physiolo | 3.04701805 |
11 | MP0000749_muscle_degeneration | 2.91538416 |
12 | MP0005365_abnormal_bile_salt | 2.71839231 |
13 | MP0002972_abnormal_cardiac_muscle | 2.64731088 |
14 | MP0000372_irregular_coat_pigmentation | 2.63611105 |
15 | MP0004087_abnormal_muscle_fiber | 2.56064865 |
16 | MP0008775_abnormal_heart_ventricle | 2.51335086 |
17 | MP0004130_abnormal_muscle_cell | 2.49827897 |
18 | MP0003806_abnormal_nucleotide_metabolis | 2.37483931 |
19 | MP0010630_abnormal_cardiac_muscle | 2.35382061 |
20 | MP0003137_abnormal_impulse_conducting | 2.30170482 |
21 | MP0001544_abnormal_cardiovascular_syste | 2.29485655 |
22 | MP0005385_cardiovascular_system_phenoty | 2.29485655 |
23 | MP0005620_abnormal_muscle_contractility | 2.16629117 |
24 | MP0006138_congestive_heart_failure | 2.07568054 |
25 | MP0000750_abnormal_muscle_regeneration | 2.03477293 |
26 | MP0004484_altered_response_of | 2.00787612 |
27 | MP0002269_muscular_atrophy | 1.98489901 |
28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95453946 |
29 | MP0006036_abnormal_mitochondrial_physio | 1.92095855 |
30 | MP0003252_abnormal_bile_duct | 1.92054219 |
31 | MP0002106_abnormal_muscle_physiology | 1.86838004 |
32 | MP0005171_absent_coat_pigmentation | 1.81096650 |
33 | MP0003828_pulmonary_edema | 1.79523226 |
34 | MP0003195_calcinosis | 1.76339146 |
35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.71940605 |
36 | MP0004085_abnormal_heartbeat | 1.68662222 |
37 | MP0005332_abnormal_amino_acid | 1.66746174 |
38 | MP0009840_abnormal_foam_cell | 1.57101687 |
39 | MP0000013_abnormal_adipose_tissue | 1.54409704 |
40 | MP0005369_muscle_phenotype | 1.51265140 |
41 | MP0000747_muscle_weakness | 1.51120219 |
42 | MP0005083_abnormal_biliary_tract | 1.46604840 |
43 | MP0010329_abnormal_lipoprotein_level | 1.45151605 |
44 | MP0001661_extended_life_span | 1.43023111 |
45 | MP0005666_abnormal_adipose_tissue | 1.41581309 |
46 | MP0000759_abnormal_skeletal_muscle | 1.41344708 |
47 | MP0002127_abnormal_cardiovascular_syste | 1.38187983 |
48 | MP0010368_abnormal_lymphatic_system | 1.36978808 |
49 | MP0005319_abnormal_enzyme/_coenzyme | 1.36569543 |
50 | MP0000569_abnormal_digit_pigmentation | 1.32725826 |
51 | MP0005670_abnormal_white_adipose | 1.31045513 |
52 | MP0003567_abnormal_fetal_cardiomyocyte | 1.29193932 |
53 | MP0004233_abnormal_muscle_weight | 1.28567368 |
54 | MP0004147_increased_porphyrin_level | 1.27665963 |
55 | MP0004270_analgesia | 1.23503307 |
56 | MP0004145_abnormal_muscle_electrophysio | 1.22202905 |
57 | MP0003705_abnormal_hypodermis_morpholog | 1.17831023 |
58 | MP0000343_altered_response_to | 1.17516332 |
59 | MP0003279_aneurysm | 1.16765010 |
60 | MP0000733_abnormal_muscle_development | 1.16379167 |
61 | MP0002118_abnormal_lipid_homeostasis | 1.14885440 |
62 | MP0005408_hypopigmentation | 1.14129481 |
63 | MP0001666_abnormal_nutrient_absorption | 1.08615452 |
64 | MP0004043_abnormal_pH_regulation | 1.08469591 |
65 | MP0005451_abnormal_body_composition | 1.07784548 |
66 | MP0003950_abnormal_plasma_membrane | 1.05699623 |
67 | MP0000266_abnormal_heart_morphology | 1.05206986 |
68 | MP0004510_myositis | 1.04479230 |
69 | MP0006035_abnormal_mitochondrial_morpho | 1.03067967 |
70 | MP0000609_abnormal_liver_physiology | 1.02902643 |
71 | MP0005165_increased_susceptibility_to | 1.02325842 |
72 | MP0009643_abnormal_urine_homeostasis | 1.01092828 |
73 | MP0009780_abnormal_chondrocyte_physiolo | 0.98724220 |
74 | MP0002332_abnormal_exercise_endurance | 0.98484269 |
75 | MP0002877_abnormal_melanocyte_morpholog | 0.94654235 |
76 | MP0005266_abnormal_metabolism | 0.92699745 |
77 | MP0003191_abnormal_cellular_cholesterol | 0.92287443 |
78 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90785660 |
79 | MP0008438_abnormal_cutaneous_collagen | 0.89314671 |
80 | MP0000230_abnormal_systemic_arterial | 0.88551750 |
81 | MP0002128_abnormal_blood_circulation | 0.86970514 |
82 | MP0002822_catalepsy | 0.86868686 |
83 | MP0003045_fibrosis | 0.86023753 |
84 | MP0005375_adipose_tissue_phenotype | 0.85466553 |
85 | MP0002638_abnormal_pupillary_reflex | 0.84779877 |
86 | * MP0002078_abnormal_glucose_homeostasis | 0.81823500 |
87 | MP0005386_behavior/neurological_phenoty | 0.80341970 |
88 | MP0004924_abnormal_behavior | 0.80341970 |
89 | MP0002876_abnormal_thyroid_physiology | 0.75346549 |
90 | MP0003136_yellow_coat_color | 0.75017387 |
91 | MP0009046_muscle_twitch | 0.74319677 |
92 | MP0002971_abnormal_brown_adipose | 0.74163770 |
93 | MP0004185_abnormal_adipocyte_glucose | 0.73877462 |
94 | MP0002138_abnormal_hepatobiliary_system | 0.73554289 |
95 | MP0003566_abnormal_cell_adhesion | 0.73409693 |
96 | MP0002234_abnormal_pharynx_morphology | 0.71499844 |
97 | MP0009384_cardiac_valve_regurgitation | 0.71304105 |
98 | MP0002108_abnormal_muscle_morphology | 0.70216050 |
99 | MP0003186_abnormal_redox_activity | 0.69611176 |
100 | MP0003868_abnormal_feces_composition | 0.68549945 |
101 | MP0000371_diluted_coat_color | 0.67180366 |
102 | MP0002009_preneoplasia | 0.66646029 |
103 | MP0001879_abnormal_lymphatic_vessel | 0.66488612 |
104 | MP0000767_abnormal_smooth_muscle | 0.66099572 |
105 | MP0000015_abnormal_ear_pigmentation | 0.63548589 |
106 | MP0009697_abnormal_copulation | 0.62891844 |
107 | MP0000598_abnormal_liver_morphology | 0.62548501 |
108 | MP0008569_lethality_at_weaning | 0.61068746 |
109 | MP0008961_abnormal_basal_metabolism | 0.58004424 |
110 | MP0004019_abnormal_vitamin_homeostasis | 0.57023272 |
111 | MP0004142_abnormal_muscle_tone | 0.55904407 |
112 | MP0001764_abnormal_homeostasis | 0.54524260 |
113 | MP0009763_increased_sensitivity_to | 0.54464678 |
114 | MP0005334_abnormal_fat_pad | 0.54207705 |
115 | MP0005253_abnormal_eye_physiology | 0.53444072 |
116 | MP0003656_abnormal_erythrocyte_physiolo | 0.51132971 |
117 | MP0002272_abnormal_nervous_system | 0.51001768 |
118 | MP0005645_abnormal_hypothalamus_physiol | 0.50721479 |
119 | MP0009745_abnormal_behavioral_response | 0.50657685 |
120 | MP0009642_abnormal_blood_homeostasis | 0.50028607 |
121 | MP0006276_abnormal_autonomic_nervous | 0.49283097 |
122 | MP0005376_homeostasis/metabolism_phenot | 0.48641481 |
123 | MP0002064_seizures | 0.48511061 |
124 | MP0004134_abnormal_chest_morphology | 0.47583724 |
125 | MP0005535_abnormal_body_temperature | 0.47484087 |
126 | MP0000003_abnormal_adipose_tissue | 0.46595711 |
127 | MP0006054_spinal_hemorrhage | 0.44976015 |
128 | MP0001765_abnormal_ion_homeostasis | 0.44463175 |
129 | MP0005636_abnormal_mineral_homeostasis | 0.43835376 |
130 | MP0005409_darkened_coat_color | 0.43155663 |
131 | MP0003959_abnormal_lean_body | 0.43085060 |
132 | MP0001984_abnormal_olfaction | 0.43075652 |
133 | MP0005551_abnormal_eye_electrophysiolog | 0.42495378 |
134 | MP0002067_abnormal_sensory_capabilities | 0.42232984 |
135 | MP0002095_abnormal_skin_pigmentation | 0.41740299 |
136 | MP0004272_abnormal_basement_membrane | 0.41608045 |
137 | MP0001756_abnormal_urination | 0.41301149 |
138 | MP0005187_abnormal_penis_morphology | 0.40779545 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 8.68765843 |
2 | Nemaline bodies (HP:0003798) | 8.52767120 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.40712622 |
4 | Sudden death (HP:0001699) | 6.47435361 |
5 | Ventricular tachycardia (HP:0004756) | 5.78855847 |
6 | Atrial fibrillation (HP:0005110) | 4.98650323 |
7 | Calf muscle hypertrophy (HP:0008981) | 4.78013111 |
8 | Myoglobinuria (HP:0002913) | 4.75871535 |
9 | Exercise-induced muscle cramps (HP:0003710) | 4.74724713 |
10 | Primary atrial arrhythmia (HP:0001692) | 4.58371994 |
11 | Hypoglycemic coma (HP:0001325) | 4.54389421 |
12 | Distal arthrogryposis (HP:0005684) | 4.54087556 |
13 | Lipoatrophy (HP:0100578) | 4.53208765 |
14 | Exercise-induced myalgia (HP:0003738) | 4.45561800 |
15 | Right ventricular cardiomyopathy (HP:0011663) | 4.44093516 |
16 | Supraventricular tachycardia (HP:0004755) | 4.42562865 |
17 | Supraventricular arrhythmia (HP:0005115) | 4.33292987 |
18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.27504034 |
19 | Ketoacidosis (HP:0001993) | 4.19821627 |
20 | Muscle fiber splitting (HP:0003555) | 4.10260640 |
21 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.03596631 |
22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.99293960 |
23 | Subaortic stenosis (HP:0001682) | 3.99293960 |
24 | Syncope (HP:0001279) | 3.99203406 |
25 | Rimmed vacuoles (HP:0003805) | 3.98937974 |
26 | Dilated cardiomyopathy (HP:0001644) | 3.98689508 |
27 | Abnormality of the calf musculature (HP:0001430) | 3.98664237 |
28 | Palpitations (HP:0001962) | 3.94934292 |
29 | Ketosis (HP:0001946) | 3.87367690 |
30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.81223790 |
31 | Neck muscle weakness (HP:0000467) | 3.80448078 |
32 | Asymmetric septal hypertrophy (HP:0001670) | 3.70099058 |
33 | Rhabdomyolysis (HP:0003201) | 3.68618517 |
34 | Hyporeflexia of lower limbs (HP:0002600) | 3.63962627 |
35 | Dicarboxylic aciduria (HP:0003215) | 3.55176917 |
36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.55176917 |
37 | Frequent falls (HP:0002359) | 3.53119974 |
38 | Myopathic facies (HP:0002058) | 3.50840739 |
39 | Round ear (HP:0100830) | 3.50061730 |
40 | Hyperammonemia (HP:0001987) | 3.49942455 |
41 | Bundle branch block (HP:0011710) | 3.45177359 |
42 | Ulnar deviation of the wrist (HP:0003049) | 3.39281907 |
43 | Ventricular arrhythmia (HP:0004308) | 3.37767338 |
44 | Hyperglycinuria (HP:0003108) | 3.32349961 |
45 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.30787202 |
46 | Prolonged QT interval (HP:0001657) | 3.23604683 |
47 | Atrioventricular block (HP:0001678) | 3.22745015 |
48 | Increased connective tissue (HP:0009025) | 3.17438069 |
49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.15904451 |
50 | Heart block (HP:0012722) | 3.15251016 |
51 | EMG: neuropathic changes (HP:0003445) | 3.15153942 |
52 | EMG: myopathic abnormalities (HP:0003458) | 3.12212291 |
53 | Generalized aminoaciduria (HP:0002909) | 3.09357474 |
54 | Areflexia of lower limbs (HP:0002522) | 3.08509724 |
55 | Hepatic necrosis (HP:0002605) | 3.02905834 |
56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.94970246 |
57 | Abnormality of glycine metabolism (HP:0010895) | 2.94970246 |
58 | Abnormal atrioventricular conduction (HP:0005150) | 2.93986135 |
59 | Cerebral edema (HP:0002181) | 2.92155915 |
60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.91432742 |
61 | Absent phalangeal crease (HP:0006109) | 2.84216313 |
62 | Deep venous thrombosis (HP:0002625) | 2.81949296 |
63 | Intrahepatic cholestasis (HP:0001406) | 2.78786185 |
64 | Generalized muscle weakness (HP:0003324) | 2.76650444 |
65 | Calcaneovalgus deformity (HP:0001848) | 2.71362270 |
66 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.69955084 |
67 | Hypoalphalipoproteinemia (HP:0003233) | 2.64296454 |
68 | Xanthomatosis (HP:0000991) | 2.61816545 |
69 | Ventricular fibrillation (HP:0001663) | 2.58751031 |
70 | Proximal tubulopathy (HP:0000114) | 2.58446233 |
71 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57524427 |
72 | Ragged-red muscle fibers (HP:0003200) | 2.54023554 |
73 | Hyperglycinemia (HP:0002154) | 2.47675806 |
74 | Metabolic acidosis (HP:0001942) | 2.47101834 |
75 | Abnormal finger flexion creases (HP:0006143) | 2.46668499 |
76 | Acute encephalopathy (HP:0006846) | 2.42396989 |
77 | Deformed tarsal bones (HP:0008119) | 2.39689806 |
78 | Renal cortical cysts (HP:0000803) | 2.36093708 |
79 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.35932958 |
80 | Hyperlipoproteinemia (HP:0010980) | 2.34898957 |
81 | Difficulty running (HP:0009046) | 2.34523605 |
82 | Scapular winging (HP:0003691) | 2.33278561 |
83 | Increased muscle lipid content (HP:0009058) | 2.33232786 |
84 | Lymphangioma (HP:0100764) | 2.30995078 |
85 | Conjunctival hamartoma (HP:0100780) | 2.29517133 |
86 | Blue irides (HP:0000635) | 2.29078554 |
87 | Nausea (HP:0002018) | 2.29030903 |
88 | Hypolipoproteinemia (HP:0010981) | 2.27819351 |
89 | Pheochromocytoma (HP:0002666) | 2.26466645 |
90 | Distal lower limb amyotrophy (HP:0008944) | 2.23617088 |
91 | Skin nodule (HP:0200036) | 2.23247792 |
92 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22588519 |
93 | Left ventricular hypertrophy (HP:0001712) | 2.21644985 |
94 | Myotonia (HP:0002486) | 2.20935056 |
95 | Lethargy (HP:0001254) | 2.18824264 |
96 | Abnormal EKG (HP:0003115) | 2.17084623 |
97 | Acute necrotizing encephalopathy (HP:0006965) | 2.15701696 |
98 | Hyperglycemia (HP:0003074) | 2.15244292 |
99 | Hepatocellular necrosis (HP:0001404) | 2.14959357 |
100 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.13910403 |
101 | Palmoplantar keratoderma (HP:0000982) | 2.13004084 |
102 | Abnormality of the foot musculature (HP:0001436) | 2.11649759 |
103 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11480224 |
104 | Lactic acidosis (HP:0003128) | 2.10443195 |
105 | Limb-girdle muscle atrophy (HP:0003797) | 2.09745093 |
106 | Gout (HP:0001997) | 2.09186720 |
107 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.05856414 |
108 | Hypoglycemic seizures (HP:0002173) | 2.05610510 |
109 | Gowers sign (HP:0003391) | 2.03189948 |
110 | Abnormality of the ischium (HP:0003174) | 2.03125833 |
111 | Hypobetalipoproteinemia (HP:0003563) | 2.01950470 |
112 | Distal lower limb muscle weakness (HP:0009053) | 2.01463246 |
113 | Hypoplastic ischia (HP:0003175) | 2.01199393 |
114 | Abnormality of alanine metabolism (HP:0010916) | 2.00834514 |
115 | Hyperalaninemia (HP:0003348) | 2.00834514 |
116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.00834514 |
117 | Dysmetric saccades (HP:0000641) | 2.00418244 |
118 | Abnormality of serum amino acid levels (HP:0003112) | 2.00058259 |
119 | Late onset (HP:0003584) | 1.99453898 |
120 | Vomiting (HP:0002013) | 1.99275687 |
121 | Neoplasm of the adrenal gland (HP:0100631) | 1.97799438 |
122 | Type 1 muscle fiber predominance (HP:0003803) | 1.96951347 |
123 | Muscular dystrophy (HP:0003560) | 1.95950113 |
124 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.95723979 |
125 | Hyperkalemia (HP:0002153) | 1.95249051 |
126 | Muscle stiffness (HP:0003552) | 1.95009124 |
127 | Hip contracture (HP:0003273) | 1.94837197 |
128 | Prolonged partial thromboplastin time (HP:0003645) | 1.94476225 |
129 | Proximal amyotrophy (HP:0007126) | 1.92787723 |
130 | Abnormality of glycolysis (HP:0004366) | 1.91514842 |
131 | Lower limb amyotrophy (HP:0007210) | 1.91412211 |
132 | Increased CSF lactate (HP:0002490) | 1.91153159 |
133 | Neoplasm of head and neck (HP:0012288) | 1.89327286 |
134 | Esophageal neoplasm (HP:0100751) | 1.89327286 |
135 | Long clavicles (HP:0000890) | 1.88911338 |
136 | Sudden cardiac death (HP:0001645) | 1.88853967 |
137 | Cholelithiasis (HP:0001081) | 1.88745689 |
138 | Hyperventilation (HP:0002883) | 1.88555871 |
139 | Increased intramyocellular lipid droplets (HP:0012240) | 1.87905683 |
140 | Malignant hyperthermia (HP:0002047) | 1.86471680 |
141 | Foot dorsiflexor weakness (HP:0009027) | 1.86045525 |
142 | Steppage gait (HP:0003376) | 1.83183436 |
143 | Fetal akinesia sequence (HP:0001989) | 1.80097495 |
144 | Neuroendocrine neoplasm (HP:0100634) | 1.74848661 |
145 | Increased serum pyruvate (HP:0003542) | 1.73649332 |
146 | Slender build (HP:0001533) | 1.70081854 |
147 | Abnormality of the calcaneus (HP:0008364) | 1.66336034 |
148 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.63753005 |
149 | Weak cry (HP:0001612) | 1.59373663 |
150 | Metatarsus adductus (HP:0001840) | 1.52225448 |
151 | Bulbar palsy (HP:0001283) | 1.50516949 |
152 | Spinal rigidity (HP:0003306) | 1.50384731 |
153 | Difficulty climbing stairs (HP:0003551) | 1.47446775 |
154 | Progressive muscle weakness (HP:0003323) | 1.46675636 |
155 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.46425983 |
156 | Limited hip movement (HP:0008800) | 1.44549534 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 5.23575708 |
2 | BCKDK | 4.04935184 |
3 | OBSCN | 3.91775279 |
4 | PKN2 | 3.85327775 |
5 | PDK4 | 3.48714734 |
6 | PDK3 | 3.48714734 |
7 | MYLK | 3.22376466 |
8 | LMTK2 | 3.17267175 |
9 | TRIB3 | 3.05186134 |
10 | PHKG2 | 2.79453455 |
11 | PHKG1 | 2.79453455 |
12 | FRK | 2.68490241 |
13 | NEK1 | 2.36125610 |
14 | DMPK | 2.32470344 |
15 | TIE1 | 2.12056833 |
16 | MARK1 | 1.99589476 |
17 | INSRR | 1.98952540 |
18 | PDK2 | 1.97875770 |
19 | FLT3 | 1.88135781 |
20 | STK24 | 1.78826959 |
21 | PIK3CA | 1.77128843 |
22 | SIK1 | 1.63808824 |
23 | WNK4 | 1.57308384 |
24 | PINK1 | 1.49954858 |
25 | MAP2K3 | 1.42591154 |
26 | STK38L | 1.30647466 |
27 | STK4 | 1.27032930 |
28 | ERN1 | 1.24372010 |
29 | EEF2K | 1.23579832 |
30 | GRK7 | 1.23312955 |
31 | FGFR4 | 1.20128396 |
32 | MAP3K7 | 1.19906553 |
33 | PAK3 | 1.11745272 |
34 | CCNB1 | 1.11254159 |
35 | PRKD1 | 1.08530072 |
36 | ZAK | 1.07829283 |
37 | SCYL2 | 1.07668373 |
38 | NEK9 | 1.07211680 |
39 | PTK6 | 1.06086396 |
40 | PRKAA2 | 1.02244409 |
41 | PDGFRA | 1.00616418 |
42 | TGFBR2 | 0.97927853 |
43 | ERBB3 | 0.93710616 |
44 | PRKAA1 | 0.93487475 |
45 | ILK | 0.93011363 |
46 | BMPR1B | 0.92322703 |
47 | TRPM7 | 0.91432032 |
48 | MUSK | 0.89446103 |
49 | WEE1 | 0.87832115 |
50 | NTRK3 | 0.86878364 |
51 | MAP2K1 | 0.85652411 |
52 | CAMK4 | 0.84830532 |
53 | KDR | 0.84304756 |
54 | CAMK2D | 0.83566353 |
55 | MAPK12 | 0.82059669 |
56 | PIK3CG | 0.81297153 |
57 | MAPK13 | 0.80326210 |
58 | MAPK7 | 0.80101939 |
59 | LIMK1 | 0.77072767 |
60 | LATS1 | 0.75158079 |
61 | ROCK1 | 0.73132570 |
62 | MAP3K5 | 0.71699922 |
63 | RIPK1 | 0.70431566 |
64 | CAMKK2 | 0.70238077 |
65 | CDC42BPA | 0.68644473 |
66 | MAPK4 | 0.66515235 |
67 | CAMK2B | 0.66343774 |
68 | ACVR1B | 0.66041168 |
69 | MAP3K10 | 0.65631787 |
70 | MAP3K3 | 0.61433212 |
71 | RPS6KL1 | 0.58957576 |
72 | RPS6KC1 | 0.58957576 |
73 | MAPK11 | 0.57891578 |
74 | PRKG1 | 0.54892191 |
75 | PAK6 | 0.52353320 |
76 | RPS6KA6 | 0.50146744 |
77 | JAK1 | 0.49135894 |
78 | SGK3 | 0.48216438 |
79 | PRKACG | 0.45488673 |
80 | STK38 | 0.44634702 |
81 | WNK1 | 0.43863331 |
82 | LRRK2 | 0.42736796 |
83 | DAPK3 | 0.42349623 |
84 | TYK2 | 0.41715818 |
85 | PNCK | 0.41668029 |
86 | RPS6KA3 | 0.41658412 |
87 | MAPKAPK5 | 0.40905498 |
88 | EPHB1 | 0.40778483 |
89 | JAK2 | 0.40554331 |
90 | PRKACB | 0.40301921 |
91 | EPHA3 | 0.39201271 |
92 | RPS6KB1 | 0.37698567 |
93 | UHMK1 | 0.37445672 |
94 | SGK2 | 0.36009927 |
95 | AKT2 | 0.35846149 |
96 | MTOR | 0.35450862 |
97 | MAPKAPK3 | 0.35148294 |
98 | WNK3 | 0.34892379 |
99 | PKN1 | 0.33955610 |
100 | TGFBR1 | 0.33706448 |
101 | SGK1 | 0.32778144 |
102 | BRSK2 | 0.32619399 |
103 | MAPK10 | 0.32351150 |
104 | RPS6KB2 | 0.32093729 |
105 | MARK3 | 0.31053027 |
106 | FER | 0.30249733 |
107 | MAP4K2 | 0.30025931 |
108 | CAMK1D | 0.29113906 |
109 | SGK494 | 0.28970677 |
110 | SGK223 | 0.28970677 |
111 | ADRBK1 | 0.28813955 |
112 | FGFR3 | 0.28607359 |
113 | PLK2 | 0.28198841 |
114 | DAPK2 | 0.27794421 |
115 | STK39 | 0.27774107 |
116 | RET | 0.27763895 |
117 | CDK4 | 0.27614830 |
118 | PRKACA | 0.27356467 |
119 | MAP3K6 | 0.26616590 |
120 | PTK2B | 0.25279147 |
121 | PDPK1 | 0.25115674 |
122 | MAP2K6 | 0.24998246 |
123 | MAP2K4 | 0.24922798 |
124 | STK11 | 0.24540021 |
125 | PRKCH | 0.24400036 |
126 | ICK | 0.24131219 |
127 | MAP3K4 | 0.23782020 |
128 | TAOK3 | 0.23604060 |
129 | PDK1 | 0.23273370 |
130 | MET | 0.23103819 |
131 | CAMK1 | 0.22536970 |
132 | STK3 | 0.22144956 |
133 | RPS6KA1 | 0.21700913 |
134 | NME2 | 0.21557929 |
135 | CAMK2A | 0.21241071 |
136 | MST1R | 0.20904374 |
137 | ITK | 0.20898117 |
138 | KSR2 | 0.20452568 |
139 | ZAP70 | 0.19411478 |
140 | ROCK2 | 0.19371557 |
141 | PRKCQ | 0.18581785 |
142 | MAPK3 | 0.17627038 |
143 | TBK1 | 0.17608983 |
144 | CAMK2G | 0.17395263 |
145 | PRKCE | 0.16266124 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.44199306 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.96569061 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.89831460 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.70436677 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.56790827 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.27957330 |
7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.75124679 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71980815 |
9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42662662 |
10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.42521464 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36026687 |
12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.17954299 |
13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.12384039 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.11497083 |
15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01259982 |
16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.96755960 |
17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.93059174 |
18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87830143 |
19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.81532519 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.81140547 |
21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.79328843 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77116768 |
23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.70811138 |
24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.66613672 |
25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65969234 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64482525 |
27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.57723947 |
28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50640543 |
29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43493491 |
30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39917169 |
31 | Lysine degradation_Homo sapiens_hsa00310 | 1.38340411 |
32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37123040 |
33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.33763831 |
34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.31652261 |
35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28837830 |
36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.27371268 |
37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26143748 |
38 | Renin secretion_Homo sapiens_hsa04924 | 1.25042898 |
39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20161062 |
40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.15305892 |
41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12726598 |
42 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11475164 |
43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11444023 |
44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10206438 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08745164 |
46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08664445 |
47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01449524 |
48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97258541 |
49 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.95593621 |
50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95478646 |
51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95423238 |
52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92541204 |
53 | Bile secretion_Homo sapiens_hsa04976 | 0.89011645 |
54 | Insulin secretion_Homo sapiens_hsa04911 | 0.88489732 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86810476 |
56 | Insulin resistance_Homo sapiens_hsa04931 | 0.85394924 |
57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82695295 |
58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81539290 |
59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80983189 |
60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80060163 |
61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78634431 |
62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77927262 |
63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76809294 |
64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74059070 |
65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73943092 |
66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71951332 |
67 | ABC transporters_Homo sapiens_hsa02010 | 0.70242904 |
68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69182481 |
69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69039029 |
70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67152377 |
71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66488881 |
72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65054660 |
73 | Salivary secretion_Homo sapiens_hsa04970 | 0.63101142 |
74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62196292 |
75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61583525 |
76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60505084 |
77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59783205 |
78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59067137 |
79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58081086 |
80 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56217400 |
81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55848177 |
82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54510440 |
83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53031436 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52446713 |
85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52030397 |
86 | Platelet activation_Homo sapiens_hsa04611 | 0.51776269 |
87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51684690 |
88 | Long-term depression_Homo sapiens_hsa04730 | 0.51517655 |
89 | Morphine addiction_Homo sapiens_hsa05032 | 0.49717472 |
90 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49366172 |
91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48041785 |
92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47599848 |
93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46520925 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46376498 |
95 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44741734 |
96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43755686 |
97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43385252 |
98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42976402 |
99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42083162 |
100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41818704 |
101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41382406 |
102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39265543 |
103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.39130468 |
104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37718793 |
105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37538102 |
106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36805810 |
107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34666156 |
108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34340730 |
109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33707936 |
110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32701313 |
111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32143873 |
112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.30978862 |
113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30314281 |
114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27347659 |
115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24817438 |
116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24686461 |
117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22379773 |
118 | Focal adhesion_Homo sapiens_hsa04510 | 0.19342368 |
119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.17943828 |
120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13780926 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13433346 |
122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09212982 |
123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.06464714 |
124 | Adherens junction_Homo sapiens_hsa04520 | 0.02572486 |
125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.00655761 |
126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.00335380 |
127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0974450 |
128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0884492 |
129 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0552058 |
130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0272897 |
131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0268680 |
132 | Amoebiasis_Homo sapiens_hsa05146 | -0.0223142 |